The Ad Campaign aims to promote the culture of preventive breast cancer screening amongst the age group of 40-55. The story beautifully touches on the nuances of fear and hesitation to speak-up about women health issues which needs to be fought back. The 2-minute-long ad
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time. Oral semaglutide will be a gamechanger for people with type 2 diabetes who prefer oral medications over injections. was
